371 related articles for article (PubMed ID: 27222534)
21. Antiviral therapy in chronic hepatitis E: a systematic review.
Peters van Ton AM; Gevers TJ; Drenth JP
J Viral Hepat; 2015 Dec; 22(12):965-73. PubMed ID: 25760481
[TBL] [Abstract][Full Text] [Related]
22. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
23. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
24. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
25. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
[TBL] [Abstract][Full Text] [Related]
26. Diversity of hepatitis E virus genotype 3.
Nicot F; Jeanne N; Roulet A; Lefebvre C; Carcenac R; Manno M; Dubois M; Kamar N; Lhomme S; Abravanel F; Izopet J
Rev Med Virol; 2018 Sep; 28(5):e1987. PubMed ID: 29939461
[TBL] [Abstract][Full Text] [Related]
27. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
[TBL] [Abstract][Full Text] [Related]
29. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
De Winter BCM; Hesselink DA; Kamar N
Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
[TBL] [Abstract][Full Text] [Related]
30. Whole genome sequencing reveals insights into hepatitis E virus genome diversity, and virus compartmentalization in chronic hepatitis E.
Melchert J; Radbruch H; Hanitsch LG; Baylis SA; Beheim-Schwarzbach J; Bleicker T; Hofmann J; Jones TC; Drosten C; Corman VM
J Clin Virol; 2023 Nov; 168():105583. PubMed ID: 37716229
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.
Debing Y; Ramière C; Dallmeier K; Piorkowski G; Trabaud MA; Lebossé F; Scholtès C; Roche M; Legras-Lachuer C; de Lamballerie X; André P; Neyts J
J Hepatol; 2016 Sep; 65(3):499-508. PubMed ID: 27174035
[TBL] [Abstract][Full Text] [Related]
32. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; Pérez R; Arbiza J; Mirazo S
J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
[TBL] [Abstract][Full Text] [Related]
33. Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment.
Gömer A; Dinkelborg K; Klöhn M; Jagst M; Wißing MH; Frericks N; Nörenberg P; Behrendt P; Cornberg M; Wedemeyer H; Steinmann E; Maasoumy B; Todt D
JHEP Rep; 2024 Mar; 6(3):100989. PubMed ID: 38434938
[TBL] [Abstract][Full Text] [Related]
34. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
[TBL] [Abstract][Full Text] [Related]
35. Brief communication: case reports of ribavirin treatment for chronic hepatitis E.
Mallet V; Nicand E; Sultanik P; Chakvetadze C; Tessé S; Thervet E; Mouthon L; Sogni P; Pol S
Ann Intern Med; 2010 Jul; 153(2):85-9. PubMed ID: 20547886
[TBL] [Abstract][Full Text] [Related]
36. Generation of a Bactrian camel hepatitis E virus by a reverse genetics system.
Zhang W; Ami Y; Suzaki Y; Doan YH; Takeda N; Muramatsu M; Li TC
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34242156
[TBL] [Abstract][Full Text] [Related]
37. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
[TBL] [Abstract][Full Text] [Related]
38. Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E.
Schulz M; Biedermann P; Bock CT; Hofmann J; Choi M; Tacke F; Hanitsch LG; Mueller T
Int J Environ Res Public Health; 2020 Jan; 17(1):. PubMed ID: 31947836
[TBL] [Abstract][Full Text] [Related]
39. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis E: an emerging global disease - from discovery towards control and cure.
Khuroo MS; Khuroo MS
J Viral Hepat; 2016 Feb; 23(2):68-79. PubMed ID: 26344932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
